FDA Inspection
Moore Clinical Research Inc.Moore Clinical Research Inc. – FDA Inspection, Oct 18, 2012
Record Details
This FDA Inspection record concerns Moore Clinical Research Inc., with an inspection on October 18, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Moore Clinical Research Inc.
- Inspection Date
- October 18, 2012
- Product Type
- Drugs
View Company Profile
ID · 497a5273-e2c0-4cdd-8982-221009597208
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 805932
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
1- 21 CFR 312.60FD-1572, protocol compliance
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Moore Clinical Research Inc.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| May 10, 2018 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Moore Clinical Research Inc.
- FDA Inspection 1054906 - 2018-05-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.